Nine Chapters Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-18,200
Closed -$438K 160
2017
Q1
$438K Buy
+18,200
New +$446K 0.59% 54
2015
Q4
Sell
-17,800
Closed -$389K 482
2015
Q3
$389K Buy
17,800
+1,500
+9% +$35.2K 0.03% 635
2015
Q2
$382K Sell
16,300
-3,800
-19% -$95.3K 0.03% 656
2015
Q1
$523K Buy
+20,100
New +$479K 0.04% 589
2014
Q4
Sell
-13,200
Closed -$240K 1162
2014
Q3
$240K Buy
+13,200
New +$264K 0.02% 790
2013
Q4
Sell
-15,700
Closed -$373K 931
2013
Q3
$373K Sell
15,700
-4,800
-23% -$103K 0.04% 495
2013
Q2
$410K Buy
+20,500
New +$513K 0.07% 388

Other funds holding SRDX

Nine Chapters Capital Management's SRDX Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Surmodics (SRDX) in Q2 2017, closing a stake of 18,200 shares — an estimated $438K sold.

Nine Chapters Capital Management first reported a position in SRDX in Q2 2013 and held it in 7 quarters. The position peaked at $523K in Q1 2015. 114 funds tracked by Wall St. Rank hold SRDX as of Q2 2017.

  • Nine Chapters Capital Management reported no remaining Surmodics position as of Q2 2017 after selling out during the quarter.
  • Nine Chapters Capital Management sold 18,200 Surmodics shares in Q2 2017, an estimated $438K.
  • Nine Chapters Capital Management first reported a position in Surmodics in Q2 2013 and held it in 7 quarters.
  • Nine Chapters Capital Management's Surmodics position peaked at $523K in Q1 2015.
  • 114 funds tracked by Wall St. Rank held Surmodics as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.